Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (196) Arrow Down
Filter Results: (196) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (266)
    • News  (29)
    • Research  (196)
    • Multimedia  (2)
  • Faculty Publications  (102)

Show Results For

  • All HBS Web  (266)
    • News  (29)
    • Research  (196)
    • Multimedia  (2)
  • Faculty Publications  (102)
← Page 7 of 196 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 28 Apr 2009
  • First Look

First Look: April 28, 2009

the United States and Germany in particular, and the United States and European Union more generally, suggests that how countries resolve tensions between protecting patients and empowering consumers will impact the international View Details
Keywords: Martha Lagace
  • October 2009 (Revised July 2013)
  • Case

Gilead Sciences, Inc.: Access Program

By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)
  • 05 Jan 2011
  • Op-Ed

Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress

for years to come. Unpredictability inflicts a heavy cost on scientific progress, whether in domains like stem-cell research or in searching for safe alternative fuels. It damages the United States' competitive position because great... View Details
Keywords: by William Sahlman; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • 01 May 2007
  • First Look

First Look: May 1, 2007

Casadesus-Masanell and Andres Hervas-Drane Abstract We study competitive interaction between two alternative models of digital content distribution over the Internet: peer-to-peer (p2p) file sharing and centralized client-server... View Details
Keywords: Sean Silverthorne
  • 26 Jun 2000
  • Research & Ideas

What’s an Internet Business Model? Ask a Health Care Professional

of Information Technology at Harvard Medical School), noted that most health care marketing in the past was centered around physicians. The basis of competition in the near future, he predicted, would shift to one driven by consumer... View Details
Keywords: by Martha Lagace; Health
  • March 1999 (Revised June 2000)
  • Case

Eli Lilly: The Evista Project

By: Steven C. Wheelwright and Matt Verlinden
Describes the creation and operation of the initial two heavyweight teams for new drug development and launch. The primary focus is on one of the teams, Evista, although comparisons to the other team, Zyprexa, are included. Lilly must decide the next phase (postlaunch)... View Details
Keywords: Projects; Groups and Teams; Operations; Management Teams; Product Development; Transition; Product Design; Business Startups; Business Plan; Product Launch; Competition; Service Operations; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Wheelwright, Steven C., and Matt Verlinden. "Eli Lilly: The Evista Project." Harvard Business School Case 699-016, March 1999. (Revised June 2000.)
  • 20 Nov 2006
  • Research & Ideas

Open Source Science: A New Model for Innovation

In a perfect world, scientists share problems and work together on solutions for the good of society. In the real world, however, that's usually not the case. The main obstacles: competition for publication and intellectual property... View Details
Keywords: by Martha Lagace
  • 17 Jun 2002
  • Research & Ideas

Entrepreneurship in Asia and Foreign Direct Investment

complicated organizational know-how, such as the pharmaceutical and electronics industries.) "The FDI that I'm looking at also has gone into industries in which the local entrepreneurs in these economies started out with some... View Details
Keywords: by Martha Lagace
  • 19 Dec 2005
  • Research & Ideas

The Regional Slice of Your Global Strategy

equipment, and pharmaceuticals have invested significantly in modern mapping technology, using such innovations as enhanced clustering techniques, better measures for analyzing networks, and expanded data on bilateral, multilateral, and... View Details
Keywords: by Pankaj Ghemawat
  • March 2009
  • Teaching Note

Proteus Biomedical: Making Pigs Fly (TN)

By: Richard G. Hamermesh
Teaching Note for [809051]. View Details
Keywords: Business Startups; Information Technology; Competition; Negotiation Deal; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G. "Proteus Biomedical: Making Pigs Fly (TN)." Harvard Business School Teaching Note 809-128, March 2009.
  • 02 Oct 2000
  • Research & Ideas

The Dubious Logic of Global Megamergers

with their mega-deals, you can exploit that fact to improve your own competitive position. For instance, while pharmaceutical players such as Glaxo Wellcome and SmithKline Beecham have made headlines with... View Details
Keywords: by Pankaj Ghemawat & Fariborz Ghadar
  • 03 Aug 2016
  • What Do You Think?

How Can We Hold the “Leadership Industry” Accountable?

these leadership industry issues varied. Pradip commented: “In a competitive industry there are many who want everyone to ‘buy in’ (to) their half baked research as ‘new truth.’” He called for a “rigorous research methodology” like what... View Details
Keywords: by James Heskett; Education
  • 06 Mar 2012
  • First Look

First Look: March 6

residential real estate and away from more productive investments. Third, the cost of professional investment management is too high, which drains talent from other industries. The financial sector could promote the health and View Details
Keywords: Sean Silverthorne
  • 17 Mar 2009
  • First Look

First Look: March 17, 2009

to combat gray markets is to increase internal transfer prices to foreign subsidiaries in order to increase the gray market's cost base. We illustrate that when a gray market competitor is present, the optimal price for internal transfers exceeds marginal cost but... View Details
Keywords: Martha Lagace
  • 10 Jan 2005
  • Research & Ideas

Motivation and the Cross-Sector Alliance

Such motives spring from the humanitarian values possessed by the organizations or individuals involved. Utilitarian motives, on the other hand, cater to the partners' organizational needs, focusing on issues like risk management or the creation of View Details
Keywords: by James Austin, Ezequiel Reficco & SEKN research team
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

in expectation. We also show that by offering both CPC and CPA, an ad platform can weakly increase its revenues compared to offering either alternative alone. Download the paper: http://www.hbs.edu/research/pdf/09-074.pdf Competition and... View Details
Keywords: Martha Lagace
  • 22 Oct 2013
  • First Look

First Look: October 22

expenditures on teammates lead to better performance in both sports teams in Canada and pharmaceutical sales teams in Belgium. These results suggest that a minor adjustment to employee bonuses-shifting the focus from the self to... View Details
Keywords: Sean Silverthorne
  • 06 Jun 2017
  • First Look

First Look at New Research and Ideas: June 6, 2017

policy debate. Positive aggregate productivity gains are often attributed to within-firm productivity improvement; however, an alternative, less emphasized explanation is between-firm selection and market reallocation, whereby competition... View Details
Keywords: Sean Silverthorne
  • 20 Feb 2018
  • First Look

First Look at New Research and Ideas, February 20, 2018

through the New Deal era. This history of American capitalism argues that business associations partnered with regulators to create codes of fair competition that reshaped both public and private regulatory power. Rather than viewing the... View Details
Keywords: Sean Silverthorne
  • ←
  • 7
  • 8
  • 9
  • 10
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.